skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures


(Last updated:11/1/2012; last reviewed:11/1/2012)

Mycobacterium tuberculosis Infection and Disease
Member Financial Disclosure
 Company Relationship
Burman, Bill* University of Colorado Otsuka Advisory Board
Tibotec DSMB Member
El-Sadr, Wafaa Columbia University None N/A
Gandhi, Neel Rollins School of Public Health-Emory University None N/A
Havlir, Diane University of California, San Francisco None N/A
Maartens, Gary University of Cape Town, South Africa Tibotec DSMB Member
Meintjes, Graeme
University of Cape Town, South Africa Sanofi-Aventis Honoraria
Samandari, Taraz Centers for Disease Control and Prevention None N/A
*Group lead
Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.